|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Nov 27 | Option Exercise | 74.10 | 27,642 | 2,048,356 | 71,844 | Nov 29 09:14 AM |
CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Nov 27 | Sale | 106.31 | 36,642 | 3,895,411 | 35,202 | Nov 29 09:14 AM |
CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Aug 28 | Option Exercise | 71.43 | 6,712 | 479,438 | 50,914 | Aug 29 04:21 PM |
CAH | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | Aug 28 | Sale | 89.81 | 6,712 | 602,805 | 44,202 | Aug 29 04:21 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite